Abemaciclib plus non-steroidal aromatase inhibitor or fulvestrant in women with HR+/HER2- advanced breast cancer: Final results of the randomized phase III MONARCH plus trial
阿贝西利联合非甾体类芳香化酶抑制剂或氟维司群治疗HR+/HER2-晚期乳腺癌女性患者:随机III期MONARCH plus试验的最终结果
期刊:Chinese Medical Journal
影响因子:7.3
doi:10.1097/CM9.0000000000003151
Hu, Xichun; Zhang, Qingyuan; Sun, Tao; Yin, Yongmei; Li, Huiping; Yan, Min; Tong, Zhongsheng; Li, Man; Teng, Yue'e; Oppermann, Christina Pimentel; Kanakasetty, Govind Babu; Portugal, Ma Coccia; Yang, Liu; Zhang, Wanli; Jiang, Zefei